EUVIMEDEUVIMED entdecken
Crossref

PNPLA3 I148M Variant Activates Hepatic Stellate Cells via AMIGO2 Upregulation Using iPSC ‐Derived Model

Katsuya Toshida iD, Kazuki Takeishi, Shinji Itoh iD, Takeshi Kurihara iD, Takashi Motomura, Takuma Ishikawa, Hitoshi Iwasaki, Junya Mita, Yuki Nakayama iD, Takahiro Tomiyama iD, Norifumi Iseda, Rodrigo M Florentino iD und 3 weitere

Liver International · 2026

DOI: 10.1111/liv.70770 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, 2026. Verfasst von Katsuya Toshida und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. Hauptthemen laut MEDLINE: Hepatic Stellate Cells, Induced Pluripotent Stem Cells, Membrane Proteins, Liver Cirrhosis. Die Arbeit nennt 38 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, NIH HHS, Suzuken Memorial Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims A variant in the patatin‐like phospholipase domain‐containing protein 3 (PNPLA3) was reported to be related to metabolic‐associated fatty liver disease. However, the mechanism by which this variant leads to liver fibrosis has not been unveiled yet. Using induced pluripotent stem cell (iPSC)‐derived hepatic stellate cells (iHSC) containing a single nucleotide polymorphism (SNP) within PNPLA3, this study sought to clarify the mechanism through which this PNPLA3 SNP induces liver fibrosis.

Methods

Two types of iPSC (PNPLA3rs73840989(C):Wild, PNPLA3rs73840989(G):Variant) were differentiated into iHSC. iHSC were activated by TGF‐β1.

Results

TGF‐β1 stimulation resulted in significantly higher secretion of the liver fibrosis markers αSMA and COL1A1 in Variant‐iHSCs than in Wild‐iHSCs. Variant‐iHSC secreted significantly more PDGF and TGF‐β and had significantly higher cell proliferative and migration ability. RNA sequencing showed that gene expression related to collagen‐containing extracellular matrix and collagen metabolic processes was elevated in Variant‐iHSC. We focused on AMIGO2 expression because Variant‐iHSC expressed significantly more AMIGO2 than Wild‐iHSC. AMIGO2 knockdown using siRNA in Variant‐iHSC significantly reduced migration and proliferation ability. Additionally, significant changes were observed in Vimentin and E‐cadherin, along with decreases in EMT activity and protein expression of αSMA and COL1A1. Staining for AMIGO2 in cirrhotic and normal liver samples showed that AMIGO2 protein expression was observed in PNPLA3‐variant samples.

Conclusions

PNPLA3 SNP‐induced liver fibrosis involves EMT of HSC via AMIGO2 expression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatic Stellate CellsInduced Pluripotent Stem CellsMembrane ProteinsLiver CirrhosisLipaseHumansAcyltransferasesPolymorphism, Single NucleotideUp-RegulationPhospholipases A2, Calcium-IndependentCell DifferentiationTransforming Growth Factor beta1Cell ProliferationCell MovementCollagen Type I

Stichwörter der Autor:innen

AMIGO2PNPLA3hepatic stellate cellhuman‐induced pluripotent stem cellsliver fibrosis

Substanzen

Membrane ProteinsAcyltransferasesPhospholipases A2, Calcium-IndependentPNPLA3 protein, humanLipaseTransforming Growth Factor beta1Collagen Type I

Autor:innen und Institutionen

  • Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Department of Hepato-Biliary-Pancreatic Surgery, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.
  • Department of Pathology, Center for Transcriptional Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

ORCID-Profile: Katsuya Toshida, Shinji Itoh, Takeshi Kurihara, Yuki Nakayama, Takahiro Tomiyama, Rodrigo M Florentino, Takeo Toshima, Tomoharu Yoshizumi

Förderung

  • Japan Society for the Promotion of Science
  • NIH HHS
  • Suzuken Memorial Foundation
  • National Institutes of Health

Zitieren

APA

Toshida, K., Takeishi, K., Itoh, S., Kurihara, T., Motomura, T., Ishikawa, T., Iwasaki, H., Mita, J., Nakayama, Y., Tomiyama, T., Iseda, N., Florentino, R. M., Toshima, T., Soto-Gutierrez, A., & Yoshizumi, T. (2026). PNPLA3 I148M Variant Activates Hepatic Stellate Cells via AMIGO2 Upregulation Using iPSC ‐Derived Model. Liver International. https://doi.org/10.1111/liv.70770

Vancouver

Toshida K, Takeishi K, Itoh S, Kurihara T, Motomura T, Ishikawa T, et al. PNPLA3 I148M Variant Activates Hepatic Stellate Cells via AMIGO2 Upregulation Using iPSC ‐Derived Model. Liver International. 2026. doi:10.1111/liv.70770

BibTeX
@article{Toshida2026,
  author = {Toshida, Katsuya and Takeishi, Kazuki and Itoh, Shinji and Kurihara, Takeshi and Motomura, Takashi and Ishikawa, Takuma and Iwasaki, Hitoshi and Mita, Junya and Nakayama, Yuki and Tomiyama, Takahiro and Iseda, Norifumi and Florentino, Rodrigo M and Toshima, Takeo and Soto-Gutierrez, Alejandro and Yoshizumi, Tomoharu},
  title = {PNPLA3 I148M Variant Activates Hepatic Stellate Cells via AMIGO2 Upregulation Using iPSC ‐Derived Model},
  journal = {Liver International},
  year = {2026},
  doi = {10.1111/liv.70770}
}
Kostenlos starten →